HIV in Brazil Daniela Zilio Larentis Infectious Disease Resident at HCPA.

Slides:



Advertisements
Similar presentations
Management of ARV 6th Advanced HIV Course, Montpellier, September 3-5, 2008 Jürgen Rockstroh, Department of Medicine I, University of Bonn, Germany.
Advertisements

HIV in Brazil Ana Paula Pfitscher Cavalheiro
Management of ART in Albania : From the European Guidelines to the real practice. Arjan Harxhi MD, MSc, PhD University Hospital Center of Tirana Mother.
HIV/AIDS situation in Serbia GORDANA J
Key1 ARV Treatment Guidelines for a Public Health Approach Product Selection for HIV Treatment Vincent Habiyambere January 2006.
Panorama of the pharmaceutical patenting and sanitary registration of ARVs drugs in Brazil: implications to access and to health industrial complex Pedro.
BORDERNETwork Training on HIV and HBV Co-Infections Dr. med. Wolfgang Güthoff / Alexander Leffers, M.A.
The new guidelines Dr Francois Venter Reproductive Health and HIV Research Unit University of the Witwatersrand Feb 2010.
Treatment of HIV Stops Transmission : Where DO We Go From Here? Cohen et al Lancet, Nov Myron S. Cohen, MD Yergan-Bate Professor Medicine, Microbiology.
HIV AND HIV MUTANTS E. Chigidi and E. Lungu University of Botswana Private Bag 0022 Gaborone, Botswana.
Terapia ARV u chorych z koinfekcją HIV/HBV/HCV – czy istnieją preferencyjne schematy ARV. Marek Beniowski.
ANTIRETROVIRAL THERAPY Dr. Samuel Mwaniki (BPharm., MSc TID, UoN) University of Nairobi ISO 9001: Certified
 After completing this session the participant should be able to:  Discuss the goals of HIV treatment.  Understand when resistance testing should be.
Comprehensive Guideline Summary Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents December 2009 AETC NRC Slide Set.
Young person with multi-class resistance: follow-up and management (with perspectives from well-resourced and resource-limited settings) Gareth Tudor-Williams.
HIV Treatment in Saskatchewan Kurt E. Williams MD FRCPC 2012/Feb/9 Saskatoon.
PRINCIPLES OF ART IN TANZANIA
Switch to DRV/r monotherapy  MONOI  MONET  PROTEA  DRV600.
Risk of Osteoporotic Fractures Associated with Cumulative Exposure to Tenofovir and Other Antiretroviral Agents Roger Bedimo, MD; Song Zhang, PhD; Henning.
Failure Therapy VIRAL RESITANCE ADHERENCE!!!!!!!!!!! DRUG INTERACTION.
2009 Recommendations for Antiretroviral Therapy in Adults and Adolescents Summary of WHO Rapid Advice December 2009 Source: WHO HIV/AIDS Department.
When to Initiate ART in Adults and Adolescents (2009 WHO Guidelines) Target PopulationClinical conditionRecommendation Asymptomatic Individuals (including.
1 Review of Antiretroviral Therapy in Adults HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Crossroads Hotel 7 th January  All adolescents & adults with HIV infection & CD4 counts less than/equal to 350 cells/mm3, including pregnant women,
Determinants of long term adherence to antiretroviral drugs among adults followed over 54 months in Dakar (Senegal) M. Ciss 1, A. Desclaux 2, K. Diop 3,
1 Introduction to ARV Therapy HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Implementation of HIV Treatment as Prevention in China Yan Zhao MD National Center for AIDS/STD Control & Prevention Chinese Center for Disease Control.
Switch to DRV/r monotherapy  MONOI  MONET  PROTEA  DRV600.
The Pregnancy Journey Open discussion. HIV and AIDS 2013 Romania Cumulative number people diagnosed with HIV since ,261 (of which 9,946 diagnosed.
ART: When to Start? – Case Discussion Roy M. Gulick, MD, MPH Professor of Medicine Chief, Division of Infectious Diseases Weill Medical College of Cornell.
Treatments, Current & Future Jon Cohen Science Magazine.
ARV Therapy Basics in the Context of Family Planning
Prevention and Care Dr S Charalambous WHO guidelines.
SPECIAL CONSIDERATIONS August
Why African Americans Must Understand and Participate in Clinical Trials and Vaccines Virginia A. Caine, M.D. Associate Professor of Medicine Division.
Annual Epidemiological Spotlight on HIV in London: 2014 data Field Epidemiology Services PHE Publications gateway number
WORLD AIDS DAY Zero new HIV infections Zero discrimination Zero AIDS-related deaths.
Washington D.C., USA, July 2012www.aids2012.org Changing Patterns of NRTI and PI Resistance Mutations Between 2006 and 2011 in ART experienced SA.
AIDS ΘΕΡΑΠΕΙΑ Κατευθυντήριες Οδηγίες ΓΕΩΡΓΙΟΣ ΠΑΝΟΣ BSc(Biomed.Eng.), CEng, MIET, MD, PhD, DTM&H(Lon), FRCP Αν. Καθηγητής Παθολογίας & Λοιμωδών Νοσημάτων.
Antiretroviral targets in the viral life cycle Viral Replication and Drug targets.
N ORTHWEST A IDS E DUCATION AND T RAINING C ENTER Treatment-Experienced Patients in Resource- Limited Settings Susan M. Graham Assistant Professor, Medicine.
N ORTHWEST A IDS E DUCATION AND T RAINING C ENTER ART Initiation in Resource-Limited Settings Susan M. Graham Assistant Professor, Medicine and Global.
Aspects of HIV in Denmark Jane Agergaard, MD, PhD Department of Infectious Diseases Aarhus University Hospital Skejby Denmark.
Human Immune Deficiency Virus Infection Dr Huda Taha Sep 2015.
Cost-effectiveness of initiating and monitoring HAART based on WHO versus US DHHS guidelines in the developing world Peter Mazonson, MD, MBA Arthi Vijayaraghavan,
SOF/VEL 400/100 mg qd N = 106 W12 > 18 years Chronic HCV infection Genotype 1-6 Naïve or pre-treatment with IFN-based regimen Compensated cirrhosis allowed*
Problems of HIV Infection in the HAART Era Akihiko Suganuma M.D. Tokyo Metropolitan Komagome Hospital Department of Infectious Diseases.
OB/GYN Review Course: Women and HIV Questions Peter G. Gulick, DO, FACP, FACOI Associate Professor.
WHO 2013 Consultative Meeting Tawanna Hotel October 15, 2013.
Switch to low dose ATV/r  LASA Study.  Design  Endpoints –Primary: proportion of patients with HIV RNA < 200 c/mL at W48 (ITT-E) ; non-inferiority.
Novel Antiretroviral Studies and Strategies
Switch to PI/r monotherapy
Antiretroviral Therapy (ART)
HIV Tutoring By Alaina Darby.
Figure 1 Inclusion criteria, exclusion criteria, and criteria for virologic failure. CDC, Centers for Disease Control and Prevention; ddC, zalcitabine;
ART 101 Successful HIV treatment usually consists of at least three drugs from two different “classes” of ARV drugs There are now six classes of ARV drugs:
Adult Guidelines Pretoria, Saturday 17th February 2018
Clinical and virologic follow-up in perinatally HIV-1-infected children and adolescents in Madrid with triple-class antiretroviral drug-resistant viruses 
Giới thiệu về điều trị ARV
Chapter 17a HIV infection and AIDS.
دستورالعمل پیشگیری از انتقال HIV از مادر به کودک
Existing WHO recommendations for Paediatric ART under review
Personalizing Statin Therapy in Patients With HIV
Results of round 1 of the Delphi survey
Forecasting for ARVs medicines
ART Use in Selected PEPFAR Countries Forecasting for ARVs to 2010 November 7-8, 2005 Rational Pharmaceutical Management Plus.
Switch to DRV/r monotherapy
Antiretroviral therapy and its complications
ARV-trial.com Switch to FTC + ddI + EFV ALIZE 1.
Figure 1. Rate of PDR in infants according to ARV exposure
Presentation transcript:

HIV in Brazil Daniela Zilio Larentis Infectious Disease Resident at HCPA

Population: (2010) living with HIV ( 2009) AIDS: (2009) Number of deaths: Reported cases/year:

Epidemiology ( ) Men/woman ratio: 1,5; Most affected strata between 30-49y, increasing in older than 50 y; – 47,7 % of infected are white ethnicity; – Pregnant woman: y Ministério da Saúde 2010

Source of HIV acquisition ( ) - Vertical transmission: 4.181

Co-infection HIV/TBC BK performedCoinfection %

HAART 1700 euros/year/pacient ( ) with treatment, Universal access since 1996, When start treatment: 1. Symptomatics 2. Asymptomatics - CD4 >500: no ART - CD : HCV, HBV, nephropathy, any cancer, VL> , high risk for CVD, - CD4 <350: ART 3. Pregnancy

Brazilian guidline for treatment - NRTI ZDV, 3TC, TDF - ddI, d4T, ABC -NNRTI EFZ, - NVP -PI ATV, LOP/r - DRV, IDV, APV -Rescue therapy: T20, raltegravir, etravirina, maravirock

Appointment: - CD4, CV, - Use of HAART, - Side efects of HAART, - Genotyping, - Advices (protect sex, immunization).

Thank you for the attention!!